GEORGE WASHINGTON UNIVERSITY
Anti-cancer vaccine targeting the host-parasite interface during fluke infection
Anti-cancer vaccine targeting the host-parasite interface during fluke infection is a funding opportunity from GEORGE WASHINGTON UNIVERSITY, up to 56808, closing August 31, 2029.
Aug 31, 2029
(1127d left)Overview
Project Summary Liver fluke infection with Opisthorchis viverrini remains problematic in East Asia and is endemic in Thailand and Laos, where ~10 million people are infected. The public health implications of this situation are substantial since there is no stronger link between a human malignancy and a eukaryotic…